Immunovia AB (publ) (IMMVF)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
At close: 04:07PM EDT
| Previous Close | 0.1500 |
| Open | 0.1500 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.1500 - 0.1500 |
| 52 Week Range | 0.1500 - 3.1550 |
| Volume | |
| Avg. Volume | 5 |
| Market Cap | 8.789M |
| Beta (5Y Monthly) | 2.73 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.9600 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PR NewswireInvitation to Immunovia's Q1 presentation
Immunovia will publish its first quarter 2024 results on April 29, 2024 at 8:30 am CET. Analysts, investors and media are invited to a webcast teleconference on the same day at 15:00 CET. The report together with the presentation slides will be available at www.immunovia.com
PR NewswireImmunovia announces updated financial calendar
Immunovia (NASDAQ Stockholm: IMMNOV), the diagnostics company with the mission to increase pancreatic cancer survival rates through early detection, updates its financial calendar for 2024.
PR NewswireImmunovia announces positive results from the model-development study for its next-generation pancreatic cancer detection test
Immunovia (NASDAQ Stockholm: IMMNOV), the diagnostics company with the mission to increase pancreatic cancer survival through early detection, today announces its next-generation pancreatic cancer test achieved both the primary and secondary endpoints in a model-development study.
© 2024 Yahoo. All rights reserved.